XEN1101
XPF-010-301
Phase 3 small_molecule active
Quick answer
XEN1101 for Focal Onset Seizures is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Xenon Pharmaceuticals
- Indication
- Focal Onset Seizures
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active